A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer: The TRANSFORMER Trial (Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance)

Grant

Date/time Interval

  • January 1, 2015 - September 29, 2017
  • Total Award Amount

  • 308040.00
  • Direct Costs

  • 209550.00
  • Sponsor Award Id

  • 2002495982
  • Contributor

  • Deshazo M.D., Mollie   Investigator